BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14050410)

  • 1. COMPARISON OF A PLACEBO, N-DIMETHYLTRYPTAMINE, AND 6-HYDROXY-N-DIMETHYLTRYPTAMINE IN MAN.
    ROSENBERG DE; ISBELL H; MINER EJ
    Psychopharmacologia; 1963 Feb; 4():39-42. PubMed ID: 14050410
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine.
    SAI-HALASZ A
    Experientia; 1962 Mar; 18():137-8. PubMed ID: 14496041
    [No Abstract]   [Full Text] [Related]  

  • 3. [JB-318 AND ATROPINE: COMPARATIVE STUDY OF THE EFFECTS INDUCED IN NORMAL SUBJECTS].
    MENOZZI C; SCARLATO G
    Arch Psicol Neurol Psichiatr; 1964; 25():205-33. PubMed ID: 14180076
    [No Abstract]   [Full Text] [Related]  

  • 4. [AUTO-OBSERVATION OF 2 EXPERIMENTAL INTOXICATIONS WITH PSILOCYBIN].
    WIART C
    Confin Psychiatr; 1963; 6():171-80. PubMed ID: 14070405
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.
    Strassman RJ; Qualls CR; Uhlenhuth EH; Kellner R
    Arch Gen Psychiatry; 1994 Feb; 51(2):98-108. PubMed ID: 8297217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].
    REDA GC; VELLA G; CANCRINI L; D AGOSTINO E
    Riv Sper Freniatr Med Leg Alien Ment; 1964 Mar; 88():7-76. PubMed ID: 14144273
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzymatic formation of psychotomimetic metabolites from normally occurring compounds.
    AXELROD J
    Science; 1961 Aug; 134(3475):343. PubMed ID: 13685339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N, N-dimethyltryptamine: an endogenous hallucinogen.
    Barker SA; Monti JA; Christian ST
    Int Rev Neurobiol; 1981; 22():83-110. PubMed ID: 6792104
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.
    Strassman RJ; Qualls CR; Berg LM
    Biol Psychiatry; 1996 May; 39(9):784-95. PubMed ID: 8731519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PERSISTENT HALLUCINOSIS FOLLOWING REPEATED ADMINISTRATION OF HALLUCINOGENIC DRUGS.
    ROSENTHAL SH
    Am J Psychiatry; 1964 Sep; 121():238-44. PubMed ID: 14233734
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
    Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
    Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
    [No Abstract]   [Full Text] [Related]  

  • 12. On the comparative ethnopharmacology of malpighiaceous and myristicaceous hallucinogens.
    McKenna DJ; Towers GH
    J Psychoactive Drugs; 1985; 17(1):35-9. PubMed ID: 3856652
    [No Abstract]   [Full Text] [Related]  

  • 13. [AUTONOMIC DISORDERS OF THE VISUAL SYSTEM DURING TREATMENTS BY PSYCHOTROPIC DRUGS].
    APPELMANS M; MICHIELS J; VERDONCK M
    Bull Soc Belge Ophtalmol; 1963; 135():399-412. PubMed ID: 14168103
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.
    Strassman RJ; Qualls CR
    Arch Gen Psychiatry; 1994 Feb; 51(2):85-97. PubMed ID: 8297216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
    Kleinman JE; Gillin JC; Wyatt RJ
    Schizophr Bull; 1977; 3(4):560-86. PubMed ID: 271353
    [No Abstract]   [Full Text] [Related]  

  • 16. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 17. Participation of retinal mechanisms in DMT hallucinations.
    Heiss WD; Hoyer J; Poustka F
    Experientia; 1973 Apr; 29(4):455-7. PubMed ID: 4513543
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular orbital studies on the conformation of hallucinogenic indolealkylamines and related compounds. The isolated molecules and the solvent effect.
    Pullman B; Courrière P; Berthod H
    J Med Chem; 1974 Apr; 17(4):439-47. PubMed ID: 4524607
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropharmacology of N,N-dimethyltryptamine.
    Carbonaro TM; Gatch MB
    Brain Res Bull; 2016 Sep; 126(Pt 1):74-88. PubMed ID: 27126737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.